Amelia Díaz-Morilla

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Pseudomonas Aeruginosa

Machine Learning

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Miguel García-Castro, David Fuentes-Rios, Juan Manuel López-Romero, Antonio Romero, Federico Moya-Utrera, Amelia Díaz-Morilla, Francisco Sarabia
n-Tuples on Scaffold Diversity Inspired by Drug Hybridisation to Enhance Drugability: Application to Cytarabine. Marine drugs 21 (12) (2023)
Miguel García-Castro, David Fuentes-Rios, Juan Manuel López-Romero, Antonio Romero, Federico Moya-Utrera, Amelia Díaz-Morilla, Francisco Sarabia
n-Tuples on Scaffold Diversity Inspired by Drug Hybridisation to Enhance Drugability: Application to Cytarabine. Marine drugs 21 (12) (2023)
Miguel García-Castro, David Fuentes-Rios, Juan Manuel López-Romero, Antonio Romero, Federico Moya-Utrera, Amelia Díaz-Morilla, Francisco Sarabia
n-Tuples on Scaffold Diversity Inspired by Drug Hybridisation to Enhance Drugability: Application to Cytarabine. Marine drugs 21 (12) (2023)
Miguel García-Castro, David Fuentes-Rios, Juan Manuel López-Romero, Antonio Romero, Federico Moya-Utrera, Amelia Díaz-Morilla, Francisco Sarabia
n-Tuples on Scaffold Diversity Inspired by Drug Hybridisation to Enhance Drugability: Application to Cytarabine. Marine drugs 21 (12) (2023)
Cristina Porras-Alcalá, Federico Moya-Utrera, Miguel García-Castro, Antonio Sánchez-Ruiz, Juan Manuel López-Romero, María Soledad Pino-González, Amelia Díaz-Morilla, Seiya Kitamura, Dennis W Wolan, Jose Carlos Prados, Consolación Melguizo, Iván Cheng-Sánchez, Francisco Sarabia
The Development of the Bengamides as New Antibiotics against Drug-Resistant Bacteria. Marine drugs 20 (6) (2022)